Friday, July 31, 2026

Lee Kang-in Travels to London to Apologize to Son Heung-min, Reconciliation Ensues

Son Heung-min has gracefully accepted an apology from his junior, Lee Kang-in, following a dispute that arose during the last Asian Cup.

Samsung Biologics Accelerates “Three-Pillar Expansion Strategy” With Peptide CDMO Acquisition to Drive Global Growth

Samsung Biologics acquires Polypeptide Group for $1.8 billion, expanding into the peptide CDMO market to enhance growth and capabilities.

HLB’s Rivoceranib Drug Approval: What the FDA’s VAI Classification Means for Liver Cancer Treatment

HLB's Rivoceranib facility received a VAI classification from the FDA, indicating compliance with GMP standards, aiding drug approval progress.

Tag: R2P

No posts to display

Top News

- Our Sponsors Ad -

Follow us